tetrahydrocurcumin has been researched along with Altitude Sickness in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, X; Li, F; Li, Y; Ma, X; Pan, Y; Tang, H; Wang, J; Yuan, J; Zhang, Y; Zhao, J; Zhao, Y | 1 |
1 trial(s) available for tetrahydrocurcumin and Altitude Sickness
| Article | Year |
|---|---|
Tetrahydrocurcumin mitigates acute hypobaric hypoxia-induced cerebral oedema and inflammation through the NF-κB/VEGF/MMP-9 pathway.
Topics: Altitude Sickness; Animals; Brain Edema; Cell Hypoxia; Curcumin; Disease Models, Animal; Humans; Inflammation; Male; Mice; NF-kappa B; Vascular Endothelial Growth Factor A | 2020 |